In addition to mechanistic and methodological insights, our findings offer hope for pharmaceutical interventions that can target cell GLP-1 production to restore islet function and treat T2DM
Michael Buontempo, a resident physician at Dartmouth-Hitchcock Medical Center, explains: Most hair shedding on GLP-1s looks like androgenetic alopecia unmasked by an episode of telogen effluvium driven by the magnitude of weight loss, rather than a direct drug toxicity. This means some people discover they have genetic hair loss when the telogen effluvium pulls away enough hair to reveal the underlying pattern
Therefore, patients with T2MD are more likely to suffer from several malignancies compared with healthy individuals
Nutritionist-recommended products for GLP-1 users include: protein supplements that can help offset a reduction in muscle mass when losing weight
Latest developments on GLP-1 patches Various pharmaceutical companies, particularly in South Korea, including Daewoong Pharmaceutical, are working on developing microneedle patches for GLP-1 drugs
.webp)
